Heart Surgery

Latest Issue of OR Manager
May 2025
Home Surgery/Specialties > Heart Surgery

Emergency departments affect postop readmission rates

Editor's Note This study by researchers at Indiana University and the University of Michigan finds that emergency departments (EDs) are a significant factor in preventing readmissions after major surgery. Researchers analyzed the electronic health records of nearly 2 million Medicare beneficiaries who had one of five surgical procedures (ie, percutaneous…

Read More

By: Judy Mathias
December 13, 2021
Share

County-level social vulnerability linked to worse postop outcomes, especially in minority patients

Editor's Note This study from the Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, finds that patients residing in vulnerable communities characterized by a high social vulnerability index (SVI) had worse postoperative outcomes, and the impact was most pronounced in Black/minority patients. In this analysis…

Read More

By: Judy Mathias
December 9, 2021
Share

FDA: Class I recall of Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump battery packs

Editor's Note The Food and Drug Administration (FDA), on October 29, identified the recall by Datascope/Getinge/Maquet of its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump battery packs as Class I, the most serious. The recall was initiated because of the risk of the battery failing and having a shortened run time, which…

Read More

By: Judy Mathias
November 1, 2021
Share

The Joint Commission seeking comments on new heart attack certification program

Editor's Note The Joint Commission, on October 27, announced that it will launch a new Comprehensive Heart Attack Center Certification in July 2022 and is seeking comments on the newly proposed standards. The Joint Commission also has revised standards for its current certification programs: Acute Heart Attack Ready and Primary…

Read More

By: Judy Mathias
October 28, 2021
Share

Sponsored Message

FDA: Class I recall of DeRoyal surgical procedure packs

Editor's Note The Food and Drug Administration (FDA), on June 25, identified the recall of DeRoyal Industries’ surgical procedure packs as Class I, the most serious. The recall was initiated because the packs contain 1% lidocaine that had been mislabeled as 0.5% bupivacaine. The procedure packs are used for cardiac…

Read More

By: Judy Mathias
June 28, 2021
Share

First assistants bring expertise and efficiency to the OR table--Part 2

First assistants (FAs) can play an important role in achieving optimal outcomes and higher surgical case volumes. Part 1 of this two-part series discussed types, education, and certification of FAs (OR Manager, May 2021, pp 1, 15-18). Part 2 answers questions related to risk management and oversight, and discusses possible…

Read More

By: Cynthia Saver, MS, RN
May 19, 2021
Share

Sponsored Message

Trends in surgical caseloads during COVID-19

Editor's Note Urban hospitals bounced back faster than rural hospitals from surgical caseload decreases caused by the COVID-19 pandemic, finds a new study released May 13 by Caresyntax, a Boston-based developer of surgical intelligence and automation technologies. The study, “The State of Surgery: An Analysis of Surgical Trends During the…

Read More

By: Judy Mathias
May 17, 2021
Share

FDA: Class I recall of Medtronic’s Extracorporeal Blood Pumping Console

Editor's Note The Food and Drug Administration (FDA), on April 20, identified the recall of Medtronic’s Bio-Console 560 Extracorporeal Blood Pumping Console as Class I, the most serious. The Console is used during heart surgery to pump and return blood to a patient during cardiopulmonary bypass. The recall was initiated…

Read More

By: Judy Mathias
April 22, 2021
Share

FDA issues Class I recall of certain Medtronic ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA), on April 12, identified the recall of Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia, and Visia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. The recall was initiated because of an unexpected and rapid…

Read More

By: Judy Mathias
April 19, 2021
Share

FDA: Class I recall of Medtronic’s Valiant Navion Thoracic Stent Graft System

Editor's Note The Food & Drug Administration (FDA), on April 9, identified the recall of Medtronic’s Valiant Navion Thoracic Stent Graft System as Class I, the most serious. The recall was initiated because of the risk of stent fractures and endoleak concerns. The system is used to repair lesions of…

Read More

By: Judy Mathias
April 12, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat